Shots:
The US FDA has granted 510(k) clearance to the AVENTUS Thrombectomy System for the treatment of pulmonary embolism (PE), expanding its prior clearance for use in the peripheral vasculature
AVENTUS was evaluated in a completed pivotal IDE trial for aspiration thrombectomy with filtered blood reinfusion in intermediate-risk PE pts, which showed rapid improvement in…
If you've ever been in a situation where surgery didn't feel right for you, interventional radiology might be the game-changer you've been looking for. This field of medicine is all about using minimally invasive techniques to treat a whole bunch of conditions—without the need for big cuts or long recovery times. So, let's break it…
Active Ingredient: rivaroxaban
Strength: 2.5 mg, 10 mg, 15 mg, and 20 mg
Dosage Form: Tablets
Mechanism of Action: Factor Xa inhibitors
First Approval: US (1 Jul 2011), EU (30 Sep 2008)
Revenue Analysis of Xarelto1
Xarelto has been an important driver of the revenue generated from the cardiovascular portfolio of Janssen. The blood thinner showed an increase of 4%…
Active Ingredients: Apixaban
Strength: 2.5 mg and 5 mg
Dosage Form: Tablet
Mechanism of Action: Factor Xa inhibitors
First Approval: US (Dec 28, 2012), EU (May 18, 2011)
Revenue1
Eliquis is a leading novel oral anticoagulant of BMS. The revenue for BMS continued to grow due to Eliquis and other recently launched new products. BMS and Pfizer jointly develop and…

